193 related articles for article (PubMed ID: 22170936)
1. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey.
Brown-Elliott BA; Biehle J; Conville PS; Cohen S; Saubolle M; Sussland D; Wengenack N; Kriel K; Bridge L; McNulty S; Vasireddy R; Wallace RJ
J Clin Microbiol; 2012 Mar; 50(3):670-2. PubMed ID: 22170936
[TBL] [Abstract][Full Text] [Related]
2. Nocardia resistant to trimethoprim- sulfamethoxazole? Maybe not.
Clin Infect Dis; 2012 Jul; 55(2):iii-iv. PubMed ID: 22912969
[No Abstract] [Full Text] [Related]
3. In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.
Mookherjee S; Shoen C; Cynamon M
Antimicrob Agents Chemother; 2012 Feb; 56(2):1133-4. PubMed ID: 22106219
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Analysis of Antimicrobial Susceptibility Profiles of
Hamdi AM; Fida M; Deml SM; Abu Saleh OM; Wengenack NL
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818815
[No Abstract] [Full Text] [Related]
6. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial-resistant nocardia isolates, United States, 1995-2004.
Uhde KB; Pathak S; McCullum I; Jannat-Khah DP; Shadomy SV; Dykewicz CA; Clark TA; Smith TL; Brown JM
Clin Infect Dis; 2010 Dec; 51(12):1445-8. PubMed ID: 21058914
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.
Bennett JE; Jennings AE
Antimicrob Agents Chemother; 1978 Apr; 13(4):624-7. PubMed ID: 352260
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
[No Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility and clinical characteristics of Nocardia isolates from a tertiary care centre diagnostic laboratory in Pakistan.
Farooqui F; Irfan S; Shakoor S; Zafar A
J Glob Antimicrob Resist; 2018 Dec; 15():219-221. PubMed ID: 30393158
[TBL] [Abstract][Full Text] [Related]
11. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
[TBL] [Abstract][Full Text] [Related]
12. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.
Glupczynski Y; Berhin C; Janssens M; Wauters G
Clin Microbiol Infect; 2006 Sep; 12(9):905-12. PubMed ID: 16882297
[TBL] [Abstract][Full Text] [Related]
13. Imipenem-resistant Nocardia cyriacigeorgica infection in a child with chronic granulomatous disease.
Hagerman A; Rodríguez-Nava V; Boiron P; Crisinel PA; Posfay-Barbe KM
J Clin Microbiol; 2011 Mar; 49(3):1185-7. PubMed ID: 21177900
[TBL] [Abstract][Full Text] [Related]
14. Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
Mittal V; Fernandes M
Can J Ophthalmol; 2012 Dec; 47(6):e58-60. PubMed ID: 23217523
[No Abstract] [Full Text] [Related]
15. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis.
Vera-Cabrera L; Gómez-Flores A; Escalante-Fuentes WG; Welsh O
Antimicrob Agents Chemother; 2001 Dec; 45(12):3629-30. PubMed ID: 11709356
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis.
Hirsh DC; Jang SS
J Am Vet Med Assoc; 1999 Sep; 215(6):815-7, 795-6. PubMed ID: 10496134
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.
Valdezate S; Garrido N; Carrasco G; Medina-Pascual MJ; Villalón P; Navarro AM; Saéz-Nieto JA
J Antimicrob Chemother; 2017 Mar; 72(3):754-761. PubMed ID: 27999029
[TBL] [Abstract][Full Text] [Related]
18. Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.
Huang L; Chen X; Xu H; Sun L; Li C; Guo W; Xiang L; Luo G; Cui Y; Lu B
Diagn Microbiol Infect Dis; 2019 Jun; 94(2):165-172. PubMed ID: 30679058
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antimicrobial susceptibility testing of Nocardia spp. isolates by broth microdilution with resazurin and spectrophotometry.
Caso Coelho V; Pereira Neves SD; Cintra Giudice M; Benard G; Lopes MH; Sato PK
BMC Microbiol; 2021 Dec; 21(1):331. PubMed ID: 34865615
[TBL] [Abstract][Full Text] [Related]
20. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
Wei M; Wang P; Qu J; Li R; Liu Y; Gu L; Yang C
J Glob Antimicrob Resist; 2017 Dec; 11():183-187. PubMed ID: 28870771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
